Artwork

Content provided by The Guardian. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Guardian or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

The extraordinary promise of personalised cancer vaccines

13:15
 
Share
 

Manage episode 415870899 series 19780
Content provided by The Guardian. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Guardian or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Glioblastomas are an extremely aggressive type of brain tumour, which is why the news this week of a vaccine that has shown promise in fighting them is so exciting. And this comes right off the back of the announcement of another trial of the world’s first personalised mRNA vaccine for melanoma, a kind of skin cancer. Ian Sample talks to Prof Alan Melcher of the Institute of Cancer Research about how these vaccines work and whether they could one day be used to target cancer before it is even detectable on scans. Help support our independent journalism at theguardian.com/sciencepod
  continue reading

731 episodes

Artwork
iconShare
 
Manage episode 415870899 series 19780
Content provided by The Guardian. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Guardian or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Glioblastomas are an extremely aggressive type of brain tumour, which is why the news this week of a vaccine that has shown promise in fighting them is so exciting. And this comes right off the back of the announcement of another trial of the world’s first personalised mRNA vaccine for melanoma, a kind of skin cancer. Ian Sample talks to Prof Alan Melcher of the Institute of Cancer Research about how these vaccines work and whether they could one day be used to target cancer before it is even detectable on scans. Help support our independent journalism at theguardian.com/sciencepod
  continue reading

731 episodes

Tous les épisodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide